MBHB Partner Kevin Noonan Quoted in TheScientist.com Article Entitled, “UC Berkeley Receives CRISPR Patent in Europe”

McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan is quoted in a March 24, 2017 edition of TheScientist.com in an article entitled, “UC Berkeley Receives CRISPR Patent in Europe.” The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S. View the article